Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 02, 2024

BUY
$1.05 - $2.9 $5,447 - $15,045
5,188 Added 4252.46%
5,310 $15,000
Q3 2023

Nov 01, 2023

BUY
$1.29 - $2.22 $157 - $270
122 New
122 $0
Q1 2023

Apr 27, 2023

SELL
$2.81 - $6.71 $53,319 - $127,322
-18,975 Reduced 92.43%
1,554 $4,000
Q4 2022

Feb 02, 2023

BUY
$3.44 - $6.87 $65,562 - $130,935
19,059 Added 1296.53%
20,529 $141,000
Q3 2022

Nov 04, 2022

BUY
$2.35 - $4.66 $1,104 - $2,190
470 Added 47.0%
1,470 $4,000
Q2 2022

Aug 03, 2022

BUY
$2.09 - $3.71 $2,090 - $3,710
1,000 New
1,000 $3,000
Q1 2022

May 02, 2022

SELL
$2.84 - $4.52 $2,467 - $3,927
-869 Closed
0 $0
Q4 2021

Feb 23, 2022

BUY
$3.87 - $6.59 $1,737 - $2,958
449 Added 106.9%
869 $3,000
Q2 2021

Aug 12, 2021

SELL
$10.15 - $17.25 $22,695 - $38,571
-2,236 Reduced 84.19%
420 $6,000
Q1 2021

Apr 26, 2021

BUY
$10.6 - $21.27 $28,153 - $56,493
2,656 New
2,656 $32,000

Others Institutions Holding STIM

About Neuronetics, Inc.


  • Ticker STIM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 27,022,800
  • Market Cap $47.3M
  • Description
  • Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...
More about STIM
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.